• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248

Professional Introduction to Compound with CAS No. 937602-11-4 and Product Name: 1-(4-{3-4-(Benzyloxy)phenoxypropoxy}-phenyl)-1-ethanone

The compound with the CAS number 937602-11-4 and the product name 1-(4-{3-4-(Benzyloxy)phenoxypropoxy}-phenyl)-1-ethanone represents a significant advancement in the field of chemical biology and pharmaceutical research. This compound, characterized by its intricate molecular structure, has garnered considerable attention due to its potential applications in drug development and therapeutic interventions.

At the core of this compound's significance lies its unique chemical architecture, which includes a benzyl oxygenation moiety and a propoxy chain extending from a phenoxy group. This structural complexity not only contributes to its distinct pharmacological profile but also opens up avenues for further exploration in medicinal chemistry. The presence of multiple aromatic rings and oxygenated functional groups suggests that this compound may exhibit a range of biological activities, making it a promising candidate for further investigation.

In recent years, there has been growing interest in compounds that can modulate cellular signaling pathways associated with inflammation, neurodegeneration, and cancer. The 1-(4-{3-4-(Benzyloxy)phenoxypropoxy}-phenyl)-1-ethanone structure bears structural similarities to known bioactive molecules that have demonstrated efficacy in preclinical studies. Specifically, the benzyl oxygenation and phenoxypropoxy components may interact with target proteins in ways that could inhibit or enhance specific enzymatic activities relevant to disease pathways.

One of the most compelling aspects of this compound is its potential to serve as a scaffold for derivative design. By modifying specific functional groups or introducing additional substituents, researchers can fine-tune its pharmacokinetic and pharmacodynamic properties. This flexibility is particularly valuable in drug discovery, where optimizing solubility, bioavailability, and target specificity is often critical for achieving therapeutic efficacy.

Recent advancements in computational chemistry have enabled more sophisticated virtual screening methods to identify promising candidates like 1-(4-{3-4-(Benzyloxy)phenoxypropoxy}-phenyl)-1-ethanone. These techniques leverage large datasets and machine learning algorithms to predict biological activity, allowing researchers to prioritize compounds for experimental validation. Such computational approaches have significantly accelerated the drug discovery pipeline, reducing the time and resources required to identify lead compounds.

The compound's potential relevance extends to several therapeutic areas. For instance, its structural features may allow it to interact with kinases or other enzymes implicated in cancer progression. Additionally, the oxygenated moieties could contribute to anti-inflammatory effects by modulating cytokine production or inhibiting inflammatory cascades. These possibilities underscore the need for rigorous preclinical evaluation to fully elucidate its therapeutic potential.

In vitro studies have already begun to explore the interactions between 1-(4-{3-4-(Benzyloxy)phenoxypropoxy}-phenyl)-1-ethanone and various biological targets. Initial results suggest that it may exhibit inhibitory effects on certain enzymes known to be overexpressed in tumor cells. Furthermore, its ability to cross cell membranes may enhance its bioavailability, making it a viable candidate for oral administration. These findings are particularly encouraging given the challenges associated with delivering effective treatments for complex diseases.

The synthesis of this compound also highlights advancements in organic chemistry methodologies. The multi-step synthesis involves precise functional group transformations, including etherification and condensation reactions, which require careful optimization to ensure high yield and purity. Such synthetic strategies are increasingly important as pharmaceutical companies seek to produce complex molecules efficiently while minimizing environmental impact.

As research progresses, collaborations between academic institutions and pharmaceutical companies will be crucial for translating laboratory findings into clinical applications. The 1-(4-{3-4-(Benzyloxy)phenoxypropoxy}-phenyl)-1-ethanone structure exemplifies how interdisciplinary approaches can drive innovation in drug development. By combining expertise in chemistry, biology, and medicine, researchers can accelerate the discovery of novel therapeutics that address unmet medical needs.

In conclusion, the compound with CAS number 937602-11-4 and product name 1-(4-{3-4-(Benzyloxy)phenoxypropoxy}-phenyl)-1-ethanone represents a significant milestone in pharmaceutical research. Its unique chemical structure, combined with promising preclinical data, positions it as a valuable tool for further exploration in drug discovery. As scientific understanding continues to evolve, this compound holds great promise for contributing to advancements in medicine and improving patient outcomes worldwide.

• 28924-21-2(3’,5’-Dibenzyloxyacetophenone)
• 937602-04-5(Methyl 4-3-(4-acetylphenoxy)propoxy-benzenecarboxylate)
• 937601-89-3(1-(4-{2-4-(Benzyloxy)phenoxyethoxy}-phenyl)-1-ethanone)
• 54696-05-8(4-Benzyloxyacetophenone)
• 34068-01-4(3-Benzyloxyacetophenone)
• 188578-95-2([1,3-Phenylenebis(methyleneoxy-4,1-phenylene)]bis(phenylmethanone))
• 72293-97-1(Ethanone, 1-[4-[(4-methoxyphenyl)methoxy]phenyl]-)
• 698982-45-5(Ethanone, 1,1'-[1,3-phenylenebis(methyleneoxy-3,1-phenylene)]bis-)
• 54589-41-2(4-Benzyloxybenzophenone)
• 94972-95-9(Methanone, (4-hydroxyphenyl)[4-(phenylmethoxy)phenyl]-)